1. Home
  2. PVLA vs CLNE Comparison

PVLA vs CLNE Comparison

Compare PVLA & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • CLNE
  • Stock Information
  • Founded
  • PVLA 2015
  • CLNE 2001
  • Country
  • PVLA United States
  • CLNE United States
  • Employees
  • PVLA N/A
  • CLNE N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • CLNE Natural Gas Distribution
  • Sector
  • PVLA Health Care
  • CLNE Utilities
  • Exchange
  • PVLA Nasdaq
  • CLNE Nasdaq
  • Market Cap
  • PVLA 604.2M
  • CLNE 526.3M
  • IPO Year
  • PVLA N/A
  • CLNE 2007
  • Fundamental
  • Price
  • PVLA $65.78
  • CLNE $2.73
  • Analyst Decision
  • PVLA Strong Buy
  • CLNE Strong Buy
  • Analyst Count
  • PVLA 12
  • CLNE 5
  • Target Price
  • PVLA $66.67
  • CLNE $3.59
  • AVG Volume (30 Days)
  • PVLA 179.9K
  • CLNE 1.5M
  • Earning Date
  • PVLA 11-15-2025
  • CLNE 11-05-2025
  • Dividend Yield
  • PVLA N/A
  • CLNE N/A
  • EPS Growth
  • PVLA N/A
  • CLNE N/A
  • EPS
  • PVLA N/A
  • CLNE N/A
  • Revenue
  • PVLA N/A
  • CLNE $420,579,000.00
  • Revenue This Year
  • PVLA N/A
  • CLNE $1.46
  • Revenue Next Year
  • PVLA N/A
  • CLNE $2.46
  • P/E Ratio
  • PVLA N/A
  • CLNE N/A
  • Revenue Growth
  • PVLA N/A
  • CLNE 4.08
  • 52 Week Low
  • PVLA $11.17
  • CLNE $1.30
  • 52 Week High
  • PVLA $65.80
  • CLNE $3.67
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 70.90
  • CLNE 58.29
  • Support Level
  • PVLA $60.49
  • CLNE $2.54
  • Resistance Level
  • PVLA $65.57
  • CLNE $2.88
  • Average True Range (ATR)
  • PVLA 3.63
  • CLNE 0.15
  • MACD
  • PVLA 0.19
  • CLNE -0.01
  • Stochastic Oscillator
  • PVLA 99.83
  • CLNE 65.91

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

Share on Social Networks: